Greetings,
I've completed my 13th session of cabazitaxel/carboplatin + daily prednisone which started in Jan of this year. I've tolerated it well with minimal size effects (peripheral neuropathy) and no nausea. I'm also getting Zometa every 4 weeks and Lupron twice/year. Bone mets on my last Bone (July) and CT (Aug) scans showed some regression and I have no bone pain. My PSA went from 51 in Jan. 2022, bottomed out at 0.40 in June and has increased to 0.88 on 10/18. My primary MO suggested I start checking on clinical trials and consult with my secondary MO, Dr. Verma at UC Davis Cancer Center. Dr. Verma recommended, since my PSA is so low and I've had 13 chemo treatments, that I drop the carboplatin for a partial chemo break but continue the cabazitaxel and watch the PSA. If it rises (already is), to re-challenge with either:
1. Lupron + Zytiga or Xtandi, no chemo (I've previously not had Xtandi) or
2. Lupron + Lynparza, no chemo (I have BRCA2 mutation)
Please share any thoughts and suggestions on the next treatment options.
Thank you for your kind consideration!